Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

“…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”

Decreased chondrocyte proliferation but no change in apoptosis in <i>ColIITg^cog</i> mice. by Louise H. W. Kung (693522)

LY411,575 decreases infection of hepatic cells by <i>P. berghei</i> ANKA sporozoites. by Iana Parvanova (12738)

<i>l</i>-THP decreased cardiac oxidative stress, TNF-α production and myocardial apoptosis. by Yi Han (194901)

“…Compared with the sham group, superoxide anion production significantly increased in vehicle group, while decreased in <i>l</i>-THP -treated group. ^#P<0.05 vs. sham group, *P<0.05 vs. vehicle group, n = 6. …”

Occupancy of Sp1 at GC1 of the topoisomerase IIα promoter decreases after doxorubicin treatment by Amram O Williams (31067)

Knockdown of Ras decreases ERK phosphorylation and increases the DENV titers in <i>Aedes</i> mosquito cells. by Wen-Quan Liu (9323021)

“…<p><b>A</b> and <b>B</b>, knockdown of Ras decreased ERK phosphorylation in <i>Aedes</i> mosquito cells. …”

Depletion of endogenous RUNX1 protein in hematopoietic cells decreases occupancy and activity of RUNX1 P1 promoter. by Milka Martinez (2267155)

“…Asterisks indicate statistically significant decrease in expression of RUNX1 hnRNA (**p<0.01, ***p<0.001).…”

Inhibition of VEGF and CaMKII in OS cells dramatically decreases tumor growth <i>in vivo</i>. by Paul G. Daft (720351)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

MiR-29b-2-5p is decreased upon <i>Shigella</i> infection. by Ushasree Sunkavalli (3916721)

Pretreatment with <i>Brucella</i> OMVs decreases the cytokine response of THP-1 cells to <i>Brucella</i> infection. by Cora N. Pollak (297433)

<i>Ex vivo</i> deletion of <i>sirt1</i> decreases expression of RUNX2 downstream targets. by Kayvan Zainabadi (502381)

“…<b>D)</b> Three other RUNX2 targets, Osteocalcin, Osteopontin, and Bone Sialoprotein (BSP), also show reduced expression in SIRT1 knockout cells (Cre), suggesting decreased transcriptional activity of RUNX2 in the absence of SIRT1. …”

Knockdown of <i>Nf1</i> in <i>Rdl</i>-expressing neurons decreases sleep and increases metabolic rate. by Elizabeth B. Brown (4582978)

Decreased bone marrow cellularity and progenitors in <i>Thra1</i>^<i>PV/+</i> mice. by Sunmi Park (2051092)

Inhibition of RIP1 or MLKL decreases morbidity and mortality during <i>S</i>. <i>marcescens</i> hemorrhagic pneumonia. by Norberto González-Juarbe (836747)

Decreased BK β1/α -subunit ratio in vascular tissues of <i>db/db</i> mice. by Angélica Rueda (105891)

Top elevated (>1.30-fold and p value <0.1) and decreased (<1.30-fold and p value <0.1) proteins from serum exosomes of patients with Raynaud’s Phenomenon with positive ANA compared with serum exosomes from patients with Raynaud’s Phenomenon with negative ANA identified by aptamer proteomics. by Sonsoles Piera-Velazquez (14295451)

“…<p>Top elevated (>1.30-fold and p value <0.1) and decreased (<1.30-fold and p value <0.1) proteins from serum exosomes of patients with Raynaud’s Phenomenon with positive ANA compared with serum exosomes from patients with Raynaud’s Phenomenon with negative ANA identified by aptamer proteomics.…”

Protein kinase A presumably downregulates LAT4 function by increasing its phosphorylation on S274 and decreasing pS297 level. by Lalita Oparija-Rogenmozere (8911535)

Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

Subjects:

Albumin-Oleic Acid Decreases Microglia Activation and Reduces NMDA NR1 Phosphorylation after SCI. by Gerardo Avila-Martin (341068)